Sumanirole Maleate

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameSumanirole Maleate
Drug Alias NameSumanirol舒马尼罗SumanirolumSumanirolePNU-95666 +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonistsDopamine D2 receptor agonistsSerotonin 1d (5-HT1d) receptor agonists
TargetsSerotonin 1a (5-HT1a) receptorDopamine D2 receptorSerotonin 1d (5-HT1d) receptor
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesPuerto Rico +[14] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksWikipedia